Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Pharmacology|January 14, 1997
The effect of Cu2+ on rat pulmonary arterial ringsT Ohnishi, T Ishizaki, F Sasaki, et al.
Cardiovascular Drugs and Therapy|June 1, 1993
Effects of nicorandil on cell proliferation and cholesteryl ester accumulation in arterial smooth muscle cells in cultureR Fujiwara, T Hayashi, Y Kutsumi, et al.
Japanese Journal of Medicine|January 1, 1989
Reappraisal of OP-1206, a prostaglandin E1 derivative in combination with low-flow oxygen inhalation therapy in chronic lung diseaseT Ishizaki, I Yamamura, H Azuma, et al.
The Journal of Biological Chemistry|June 30, 1995
Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipaseS Takahashi, J Suzuki, M Kohno, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1992
[Leukotoxin, 9,10-epoxy-12-octadecenoate, causes vasodilation in isolated pulmonary artery rings preconstricted with endothelin 1]H Takahashi, T Ishizaki, S Ameshima, et al.
Diabetes Research and Clinical Practice|October 1, 1990
Plasma thrombomodulin concentration in diabetes mellitusK Oida, H Takai, H Maeda, et al.
The American Journal of Cardiology|January 15, 1995
Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose toleranceR Fujiwara, Y Kutsumi, T Hayashi, et al.
Artery|January 1, 1985
Effects of insulin on hypercholesterolemia in the streptozotocin-induced diabetic rats fed a high cholesterol dietT Nakai, K Oida, Y Kutsumi, et al.
The American Journal of Physiology|July 1, 1995
Leukotoxin, 9,10-epoxy-12-octadecenoate causes edematous lung injury via activation of vascular nitric oxide synthaseT Ishizaki, K Shigemori, T Nakai, et al.
Life Sciences|January 1, 1991
Endothelin-3 stimulates the hypothalamic-pituitary-adrenal axisM Hirai, S Miyabo, E Ooya, et al.
Pageof 10